Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1681 AL 1695

De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report

Agüero P, Sainz MJ, Téllez R, Lorda I, Ávila A, García-Ribas G, Rodríguez PP, Gómez-Tortosa E.

J Alzheimers Dis. 2021;83(3):1011-1016. doi: 10.3233/JAD-210420.

Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases

Pérez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R.

Adv Exp Med Biol. 2021;1264:81-92. doi: 10.1007/978-3-030-57369-0_6.

Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?

Rahimian R, Béland LC, Sato S, Kriz J.

Med Res Rev. 2021 Jul;41(4):2582-2589. doi: 10.1002/med.21784. Epub 2021 Mar 18.

Role of connexins in neurodegenerative diseases (Review)

Xing J, Xu C.

Mol Med Rep. 2021 May;23(5):395. doi: 10.3892/mmr.2021.12034. Epub 2021 Mar 24.

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease

Kim J.

Int J Mol Sci. 2021 Mar 13;22(6):2929. doi: 10.3390/ijms22062929.

Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease

Okazawa H.

Neuropathology. 2021 Apr;41(2):93-98. doi: 10.1111/neup.12738.

Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist

Oldan JD, Jewells VL, Pieper B, Wong TZ.

AJNR Am J Neuroradiol. 2021 Jun;42(6):998-1007. doi: 10.3174/ajnr.A7079. Epub 2021 Apr 29.

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease

Balmik AA, Chinnathambi S.

Cell Commun Signal. 2021 May 7;19(1):51. doi: 10.1186/s12964-021-00732-z.

How well do people living with neurodegenerative diseases manage their finances? A meta-analysis and systematic review on the capacity to make financial decisions in people living with neurodegenerative diseases

Bangma DF, Tucha O, Tucha L, De Deyn PP, Koerts J.

Neurosci Biobehav Rev. 2021 Aug;127:709-739. doi: 10.1016/j.neubiorev.2021.05.021. Epub 2021 May 28.

When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease

D'Mello SR.

Int J Mol Sci. 2021 May 31;22(11):5911. doi: 10.3390/ijms22115911.

Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases

Trudler D, Ghatak S, Lipton SA.

Int J Mol Sci. 2021 Jul 30;22(15):8196. doi: 10.3390/ijms22158196.

Early onset Alzheimer's disease - a case study

Łabuz-Roszak B, Torbus-Paluszczak M, Becelewski J, Becelewski M, Dobrakowski P, Pierzchała K.

Psychiatr Pol. 2021 Apr 30;55(2):323-330. doi: 10.12740/PP/OnlineFirst/114122. Epub 2021 Apr 30.

Ophthalmic manifestations of dementing disorders

Douglas VP, Douglas KAA, Cestari DM.

Curr Opin Ophthalmol. 2021 Nov 1;32(6):515-520. doi: 10.1097/ICU.0000000000000807.

Single-cell Transcriptional Changes in Neurodegenerative Diseases

Ahmadi A, Gispert JD, Navarro A, Vilor-Tejedor N, Sadeghi I.

Neuroscience. 2021 Dec 15;479:192-205. doi: 10.1016/j.neuroscience.2021.10.025. Epub 2021 Nov 6.

Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease

Adeyemi OS, Awakan OJ, Afolabi LB, Rotimi DE, Oluwayemi E, Otuechere CA, Ibraheem O, Elebiyo TC, Alejolowo O, Arowolo AT.

Oxid Med Cell Longev. 2021 Nov 10;2021:5522981. doi: 10.1155/2021/5522981. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias